Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation

  title={Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation},
  author={S. Gur and P. Kadowitz and W. Hellstrom},
  journal={Expert Opinion on Drug Safety},
  pages={81 - 90}
  • S. Gur, P. Kadowitz, W. Hellstrom
  • Published 2013
  • Medicine
  • Expert Opinion on Drug Safety
  • Introduction: Treatment with 5-alpha reductase inhibitors (5ARI) is commonly utilized for the treatment of benign prostatic hyperplasia (BPH). The true prevalence of sexual side effects with 5ARI treatment is currently unknown. Areas covered: The current article reviews the reported adverse effects of 5ARI in regard to erectile function, sexual desire and ejaculation. A PubMed search was performed of all articles from 1990 to present, which reported any sexual side effects with finasteride or… CONTINUE READING
    67 Citations
    Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
    • 9
    • PDF
    Endocrinologic Control of Men's Sexual Desire and Arousal/Erection.
    • 80
    • PDF


    5-alpha reductase inhibitors and erectile dysfunction: the connection.
    • 63
    Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life
    • 70
    • PDF
    Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?
    • 201
    • Highly Influential
    Impact of medical treatments for benign prostatic hyperplasia on sexual function
    • 108
    Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
    • 17
    Dutasteride: A Review of Current Data on a Novel Dual Inhibitor of 5α Reductase
    • 25
    Recent insights into androgen action on the anatomical and physiological substrate of penile erection.
    • 60
    • PDF